Diaceutics PLC (DXRX)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 200.50 |
|---|---|
| 52-week range | 125.00 – 210.00 |
| Return, 1 month / 3 months | +3.9% / +56.6% |
| Return, 1 year / 3 years | +24.9% / +140.1% |
| Trend | Uptrend |
| RSI (14) | 64 |
| Volatility (1 year) | 33.7% |
| Worst drawdown (1 year) | -28.3% |
| Average daily value traded | 43.93M GBX |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Diaceutics is a healthcare data and advisory company based in Belfast that works with pharmaceutical and diagnostic firms on precision medicine. It gathers and analyses testing and diagnostic data, then advises drug makers on how to connect their treatments with the patients most likely to benefit. Its services support the development and commercialisation of companion diagnostics, which pair a medicine with a test that identifies suitable patients.
On this site Diaceutics PLC appears as a stock on the London Stock Exchange (UK), code DXRX, with prices in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Diaceutics PLC (DXRX) trades on the London Stock Exchange in UK. It last closed at GBX 200.50 on 27 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 239 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 24.9% and over the last three months it rose 56.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 87 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 26.4% | ||
| From 52-week high | -2.0% | ||
| Momentum | 81 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 56.6% | ||
| 6-month return | 14.9% | ||
| 12-month return, skipping the last month | 20.2% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.3% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 43.93M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.0% |
|---|---|
| 1 month | +3.9% |
| 3 months | +56.6% |
| 6 months | +14.9% |
| 1 year | +24.9% |
| 3 years | +140.1% |
| 5 years | +83.1% |
Signals
| 50-day / 200-day average | 174.98 / 158.65 |
|---|---|
| Golden / death cross (60 days) | Golden, 18 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.56 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.